查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1635820

家庭分子检测市场：全球产业分析、市场规模、占有率、成长、趋势与未来预测（2025-2032）

At-Home Molecular Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 221 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球家庭分子检测市场的详细报告。该报告对市场推动因素、趋势、机会和课题等关键市场动态进行了全面的分析，并对市场结构提供了深入的见解。

重要见解

  • 家庭分子检测市场规模（2025年）：118亿美元
  • 市场规模预测（价值基础，2032 年）：178 亿美元
  • 全球市场成长率（CAGR，2025-2032）：6.2%

家庭分子检测市场：分析范围

家用分子检测市场包括各种诊断试剂盒和解决方案，可在家中进行检测以检测特定的生物标记、病原体和遗传状况。这些产品的设计着重于便利性、准确性和易用性，可满足消费者的各种需求，包括疾病诊断、遗传易感性测试和健康监测。该市场服务于不同的领域，包括直接面向消费者的管道、零售商、线上平台和医疗保健提供者。这一增长的推动因素包括：对便捷且可获得的诊断解决方案的需求不断增长、分子检测技术的进步以及慢性病和传染病患者病率不断上升。

市场成长动力：

有几个关键因素正在推动全球家庭分子检测市场的发展。人们对预防保健和早期疾病诊断的认识不断提高，推动了家庭分子检测解决方案的采用。聚合酶炼式反应（PCR）和等温扩增技术等分子诊断技术的进步使得用户友好且准确的检测试剂盒的开发成为可能。此外，生活方式疾病的日益流行和个人化医疗需求的不断增长也刺激了市场的扩张。加强研发活动以及测试格式和应用的创新，透过为具有不同医疗需求的消费者提供客製化解决方案，进一步促进市场扩张。

市场阻碍因素：

儘管成长前景看好，但家庭分子检测市场面临着与先进诊断试剂盒成本高以及对某些家庭检测的准确性和可靠性的担忧有关的课题。新兴市场消费者认知度低以及产品审批监管障碍可能会阻碍市场成长。此外，分子检测过程的复杂性可能会阻碍不熟悉诊断工具的消费者采用。解决这些问题需要持续投资于产品创新、消费者教育，并努力简化测试程序，同时保持准确性和可负担性。

市场机会：

由于远距医疗和数位健康平台的日益普及，以及与家庭分子检测解决方案的无缝集成，市场提供了巨大的机会。基于 CRISPR 的诊断和即时核酸检测等尖端技术的开发正在满足对快速准确结果日益增长的需求。扩大销售网络，尤其是透过线上管道，可以为公司提供更广泛的市场覆盖率，并提高最终用户的可访问性。与医疗保健提供者建立策略合作伙伴关係以及对资料安全和隐私的投资对于利用新的商机和在这个不断发展的市场中保持消费者信任至关重要。

本报告回答的关键问题

  • 推动全球家庭分子检测市场成长的关键因素有哪些？
  • 哪些类型的家庭分子测试在不同消费者群体中广泛采用？
  • 技术进步如何影响家庭分子侦测市场的竞争格局？
  • 家庭分子检测市场的主要参与者是谁？他们采取了什么策略来保持竞争力？
  • 全球家庭分子检测市场的新兴趋势和未来前景如何？

目录

第1章 执行摘要

第2章 市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
    • 任务
    • 主要趋势
  • 产品生命週期分析
  • 首页 分子检测市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 用途一览
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP增长展望
    • 全球母公司市场概览
  • 预测因素：相关性和影响
  • 监管和技术格局

第 3 章 全球家庭分子检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及年成长率
    • 绝对的获利机会
  • 市场规模分析及预测（价值（十亿美元））
    • 历史市场规模分析（2019-2023）
    • 目前市场规模预测（2025-2032）
  • 全球家庭分子检测市场展望（依产品划分）
    • 简介/主要发现
    • 按产品划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 目前市场规模预测（按产品划分，价值（十亿美元）和数量，2025 年至 2032 年）
      • 卡式磁带
      • 条
      • 测试板
      • 浸卡
      • Midstream
      • 其他
  • 按产品进行市场吸引力分析
  • 全球家庭分子检测市场前景（按检测类型）
    • 简介/主要发现
    • 按测试类型划分的历史市场规模表现（价值（十亿美元）和数量，2019 年至 2023 年）
    • 按测试类型划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 怀孕测试
      • 艾滋病毒检测
      • 糖尿病
      • 感染
      • 葡萄糖测试
      • 排卵预测测试
      • 药物滥用测试
      • 其他
  • 按测试类型进行市场吸引力分析
  • 全球家庭分子检测市场展望（按样本类型）
    • 简介/主要发现
    • 按样本类型划分的历史市场规模表现（价值（十亿美元）和数量，2019-2023 年）
    • 按样本类型划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 尿
      • 血液
      • 唾液
      • 其他
  • 依样本类型进行市场吸引力分析
  • 全球家庭分子检测市场前景（依分销管道划分）
    • 简介/主要发现
    • 按分销管道划分的历史市场规模表现（价值（十亿美元）和数量，2019-2023 年）
    • 按分销管道划分的当前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
      • 零售药店
      • 药店
      • 超市/大卖场
      • 网上药店
  • 市场吸引力分析：按分销渠道

第 4 章 全球家庭分子检测市场按地区展望

  • 主要亮点
  • 按地区划分的历史市场规模分析（价值（十亿美元）和数量，2019 年至 2023 年）
  • 各地区目前市场规模预测（价值（十亿美元）和数量，2025 年至 2032 年）
    • 北美
    • 欧洲
    • 东亚
    • 南亚/大洋洲
    • 拉丁美洲
    • 中东/非洲
  • 市场吸引力分析：按地区

第 5 章 北美家庭分子检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 6 章 欧洲家庭分子检测市场展望：历史（2019-2023）与预测（2025-2032）

第 7 章 东亚家庭分子检测市场展望：历史资料（2019-2023 年）与预测（2025-2032 年）

第 8 章 南亚和大洋洲家庭分子检测市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章 拉丁美洲家庭分子检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 10 章中东和非洲家庭分子检测市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第11章 竞争格局

  • 市场占有率分析（2024 年）
  • 市场结构
    • 竞争加剧地图：按市场划分
    • 比赛仪表板
    • 产品生产能力（表观价值）：依产品分类
  • 公司简介（详细资料：概述、财务状况、策略、最新发展）
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd
    • Sensing Self
    • PTE. Ltd
    • Atomo Diagnostics
    • Mankind Pharma

第 12 章 附录

  • 分析方法
  • 分析前提条件
  • 缩写
简介目录
Product Code: PMRREP33685

Persistence Market Research has recently published an extensive report on the global At-Home Molecular Testing Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • At-Home Molecular Testing Market Size (2025E): USD 11.8 Bn
  • Projected Market Value (2032F): USD 17.8 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.2%

At-Home Molecular Testing Market - Report Scope:

The At-Home Molecular Testing Market encompasses a range of diagnostic kits and solutions that allow individuals to perform tests at home for detecting specific biomarkers, pathogens, or genetic conditions. These products are designed for convenience, accuracy, and ease of use, catering to a wide variety of consumer needs, including disease diagnosis, genetic predisposition testing, and health monitoring. The market serves diverse segments, including direct-to-consumer channels, retail outlets, online platforms, and healthcare providers. Growth is driven by increasing demand for convenient and accessible diagnostic solutions, technological advancements in molecular testing, and the rising prevalence of chronic and infectious diseases.

Market Growth Drivers:

Several key factors are driving the global At-Home Molecular Testing Market. The rising awareness of preventive healthcare and early disease diagnosis is boosting the adoption of at-home molecular testing solutions. Technological advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and isothermal amplification techniques, have enabled the development of user-friendly and accurate testing kits. Additionally, the increasing prevalence of lifestyle diseases, coupled with the growing demand for personalized medicine, is fueling market expansion. Enhanced research and development activities, along with innovations in test formats and applications, further contribute to market growth by offering tailored solutions for consumers with diverse healthcare needs.

Market Restraints:

Despite promising growth prospects, the At-Home Molecular Testing Market faces challenges related to the high costs of advanced diagnostic kits and concerns regarding the accuracy and reliability of certain at-home tests. Limited consumer awareness in developing regions and regulatory hurdles for product approval can hinder market growth. Additionally, the complexity of molecular testing processes may deter adoption among consumers unfamiliar with diagnostic tools. Addressing these issues requires continuous investment in product innovation, consumer education, and efforts to simplify test procedures while maintaining accuracy and affordability.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of telemedicine and digital health platforms, which integrate seamlessly with at-home molecular testing solutions. The development of advanced technologies, such as CRISPR-based diagnostics and point-of-care nucleic acid testing, caters to the growing need for rapid and accurate results. Expanding distribution networks, particularly through online channels, provides companies with broader market reach and enhances accessibility for end-users. Strategic collaborations with healthcare providers and investments in data security and privacy are essential for capitalizing on emerging opportunities and maintaining consumer trust in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the At-Home Molecular Testing Market globally?
  • Which types of at-home molecular tests are leading adoption across different consumer segments?
  • How are technological advancements influencing the competitive landscape of the At-Home Molecular Testing Market?
  • Who are the key players in the At-Home Molecular Testing Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global At-Home Molecular Testing Market?

Competitive Intelligence and Business Strategy:

Leading players in the global At-Home Molecular Testing Market, including Abbott Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche AG, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, such as multiplexed tests and portable devices. Collaborations with telehealth providers, distributors, and e-commerce platforms facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and targeted marketing strategies fosters market growth and enhances brand loyalty in the dynamic At-Home Molecular Testing Market landscape.

Key Companies Profiled:

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.

At-Home Molecular Testing Market Industry Segmentation:

By Product:

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others

By Test Type:

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

By Sample Type:

  • Urine
  • Blood
  • Saliva
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Test Type, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Sample Type, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations